Showing results (161-170 of 201) with videos related to
Sort By:
Pageof 21
Structure (London, England : 1993)|June 5, 2012
The T4 phage SF1B helicase Dda is structurally optimized to perform DNA strand separationXiaoping He, Alicia K Byrd, Mi-Kyung Yun, et al.Journal of Hepatology|January 15, 2008
The tumor suppressor gene DLEC1 is frequently silenced by DNA methylation in hepatocellular carcinoma and induces G1 arrest in cell cycleGuo-Hua Qiu, Manuel Salto-Tellez, James A Ross, et al.Forensic Science International|May 22, 2012
Deterring gun crime materially using forensic coatingsPaul A Sermon, Myles P Worsley, Yu Cheng, et al.British Journal of Hospital Medicine (London, England : 2005)|November 24, 2025
Research Mentorship Models in Hospital Medicine: A Narrative ReviewNidhi Rohatgi, Valerie Michele Vaughn, Ebrahim Barkoudah, et al.The Science of the Total Environment|December 16, 2014
Personal exposure monitoring of PM2.5 in indoor and outdoor microenvironmentsSusanne Steinle, Stefan Reis, Clive E Sabel, et al.Journal of Medicinal Chemistry|October 24, 2023
Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory DisordersDavid Harrison, Andy Billinton, Mark G Bock, et al.The Journal of Pharmacology and Experimental Therapeutics|January 22, 2024
Target Cell Activation of a Structurally Novel NOD-Like Receptor Pyrin Domain-Containing Protein 3 Inhibitor NT-0796 Enhances PotencyPamela Smolak, MyTrang Nguyen, Christine Diamond, et al.ACS Medicinal Chemistry Letters|August 18, 2022
Discovery and Optimization of Triazolopyrimidinone Derivatives as Selective NLRP3 Inflammasome InhibitorsDavid Harrison, Mark G Bock, John R Doedens, et al.International Journal of Epidemiology|February 18, 2022
Association between smoking, e-cigarette use and severe COVID-19: a cohort studyMin Gao, Paul Aveyard, Nicola Lindson, et al.RSC Medicinal Chemistry|September 8, 2025
Profile of NT-0527, a brain penetrant NLRP3 Inflammasome inhibitor suitable as an in vivo tool compound for neuroinflammatory disordersDavid Harrison, Andy Billinton, Mark G Bock, et al.Pageof 21